Vericel Corp. (VCEL)

40.19 -0.28 (-0.69%) USD  |  NASDAQ  |  Sep 04, 16:00
40.19 0.00 (0.00%) After-Hours: 20:00
More

Vericel SG&A Expense (TTM) : 180.98M for June 30, 2026

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for VCEL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical SG&A Expense (TTM) Data

View and export this data back to 1997. Start Trial.
Date Value
June 30, 2026 180.98M
March 31, 2026 174.41M
December 31, 2025 166.99M
September 30, 2025 158.63M
June 30, 2025 156.84M
March 31, 2025 150.20M
December 31, 2024 142.79M
September 30, 2024 138.57M
June 30, 2024 130.53M
March 31, 2024 125.91M
December 31, 2023 121.00M
September 30, 2023 117.04M
June 30, 2023 114.03M
March 31, 2023 110.52M
December 31, 2022 106.90M
September 30, 2022 105.95M
June 30, 2022 101.75M
March 31, 2022 100.80M
December 31, 2021 97.59M
September 30, 2021 89.86M
June 30, 2021 83.13M
March 31, 2021 73.43M
December 31, 2020 68.84M
September 30, 2020 66.97M
June 30, 2020 65.92M
Date Value
March 31, 2020 65.69M
December 31, 2019 61.14M
September 30, 2019 58.45M
June 30, 2019 56.04M
March 31, 2019 51.57M
December 31, 2018 49.01M
September 30, 2018 45.50M
June 30, 2018 41.11M
March 31, 2018 38.16M
December 31, 2017 35.61M
September 30, 2017 33.35M
June 30, 2017 32.18M
March 31, 2017 29.79M
December 31, 2016 27.39M
September 30, 2016 25.21M
June 30, 2016 23.87M
March 31, 2016 23.01M
December 31, 2015 22.48M
September 30, 2015 21.24M
June 30, 2015 19.88M
March 31, 2015 17.88M
December 31, 2014 13.77M
September 30, 2014 10.88M
June 30, 2014 7.637M
March 31, 2014 5.616M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
AbbVie, Inc. 14.67B
ADMA Biologics, Inc. 103.25M
Kyntra Bio, Inc. 27.67M
Conexeu Sciences, Inc. 0.0238M
ACADIA Pharmaceuticals, Inc. 620.29M